Newsbot

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from a discrete choice experiment highlighting preferred healthcare provider (HCP) treatment attributes when selecting a VMAT2 inhibitor for the treatment of TD in older patients (aged ?55 years). The new findings were presented at Psych Congress, held September 15 – 19, 2026, in New Orleans, LA.

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new real-world data evaluating treatment continuity, healthcare resource utilization (HCRU) and clinical outcomes among adults with schizophrenia and bipolar I disorder (BD-I) treated with UZEDY (risperidone) extended-release injectable suspension. The results demonstrate how UZEDY helps patients with schizophrenia remain on t...

Teva Announces New Olanzapine LAI (TEV-749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of new olanzapine LAI (TEV-749) post hoc data from the pivotal SOLARIS Phase 3 trial as well as analyses supporting treatment switch strategies. The SOLARIS data highlighted the acute and long-term durability, efficacy and safety of TEV-749 as a once-monthly subcutaneous long-acting injectable (LAI) formulat...

US, China discuss cutting tariffs on US LNG ahead of Xi visit

The US and China are discussing a plan to reduce or eliminate Chinas tariffs on American LNG as part of a broader package of energy and agriculture agreements that could be announced when Chinese President Xi Jinping visits Washington next week, according to two people briefed ?on the discussions.

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune and inflammatory diseases, today announced that on September 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchas...

Enact Receives Ratings Upgrade from AM Best

Underscores Enact’s Continued Strong Performance and Robust Capital Position Underscores Enact’s Continued Strong Performance and Robust Capital Position

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2026

EXTON, Pa., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Omega Flex, Inc. (the “Company”) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on October 14, 2026, to shareholders of record on September 30, 2026. In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisi...

FEED-Treffen in Ningbo bekräftigt volles Vertrauen in die endgültige Investitionsentscheidung (FID) im ersten Quartal 2027 für das durch einen Präsidialerlass gestützte SAF- und e-SAF-Projekt von Allied Biofuels im Wert von 6,1 Milliarden US-Dollar

NINGBO, China--(BUSINESS WIRE)--Allied Biofuels hat im Büro von Sinopec in Ningbo (China) eine wichtige Besprechung zur FEED-Planung (Front-End Engineering Design) abgehalten. Daran nahmen Allied Biofuels sowie die wichtigsten internationalen Engineering- und Technologieanbieter teil, die das auf 6,1 Milliarden US-Dollar veranschlagte und durch ein Präsidialdekret unterstützte Projekt für nachhaltigen Flugkraftstoff (SAF) und e-SAF in Usbekistan begleiten: Sinopec Engineering Group Co., Ltd. (C

RBC belässt Volkswagen auf Outperform - Ziel 120 Euro

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Volkswagen (VW) nach einer deutlichen Gewinnwarnung auf "Outperform" mit einem Kursziel von 120 Euro belassen. Die Konsensschätzungen enthielten bereits etliche der aktuellen Ankündigungen des Autobauers, die Einfluss auf das operative Ergebnis (Ebit) und den freien Barmittelzufluss hätten, schrieb Tom Narayan am Freitag in einer ersten Reaktion. [mehr]

3 Unyielding Growth Stocks to Buy Now

Three consumer brands are making very different bets on growth, and all three have something to prove over the next few years.

QIAGEN beruft Außerordentliche Hauptversammlung zur Bestellung von Jonathan M. Pratt in die Geschäftsführung ein

VENLO, Niederlande--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass am 6. November 2026 um 14:00 Uhr MEZ eine Außerordentliche Hauptversammlung stattfinden wird. Die Aktionärinnen und Aktionäre werden über die Bestellung von Jonathan M. Pratt in die Geschäftsführung von QIAGEN abstimmen, nachdem er seine Position als Chief Executive Officer (CEO) von QIAGEN am 1. September 2026 angetreten hatte. Vorbehaltlich der Zustimmung der Aktionärin

XCharge Reports First Half 2026 Unaudited Financial Results

HAMBURG, Germany and AUSTIN, Texas, Sept. 18, 2026 (GLOBE NEWSWIRE) -- XCHG Limited (“XCharge” or the “Company”) (Nasdaq: XCH), a global provider in high-power EV charging solutions, today reported its unaudited financial results for the six months ended June 30, 2026.

Mr. Bean Goes Solar

A new study focused on previously untested leguminous crops, specifically organic green bush beans, exploring thirteen different solar shading to increase revenue.

Nike: Das Drama geht weiter

Die Aktie des US-Sportartikelhersteller Nike befindet sich weiterhin auf Talfahrt. Innerhalb der vergangenen 52 Wochen hat sich der Kurs bereits mehr als halbiert. Und die jüngsten Zahlen und Meldungen des Konzerns machen aktuell eher wenig Mut, dass in Kürze die Trendwende eingeleitet wird – eher im Gegenteil.

Why Bitcoin Is Up Today

Bitcoin is higher Friday as oil prices retreat and the SEC offers limited relief for tokenized-stock trading.